OXOTREMORINE M

C[N+](C)(C)CC#CCN1CCCC1=O

InChIKey=CANZROMYQDHYHR-UHFFFAOYSA-N

InChI=1S/C11H19N2O/c1-13(2,3)10-5-4-8-12-9-6-7-11(12)14/h6-10H2,1-3H3/q+1

Targets

Primary Target	Pharmacology	Potency
Muscarinic acetylcholine receptor M3 160 Target ID: CHEMBL245 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20716489 \| https://www.ncbi.nlm.nih.gov/pubmed/7952877	Agonist 2752	1.8 µM [EC50]
Muscarinic acetylcholine receptor M5 63 Target ID: CHEMBL2035 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20716489 \| https://www.ncbi.nlm.nih.gov/pubmed/7952877	Agonist 2752	2.3 µM [EC50]
Muscarinic acetylcholine receptor M1 168 Target ID: CHEMBL216 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20716489 \| https://www.ncbi.nlm.nih.gov/pubmed/7952877	Agonist 2752	7.4 µM [EC50]

Name

Type

Language

2-BUTYN-1-AMINIUM, N,N,N-TRIMETHYL-4-(2-OXO-1-PYRROLIDINYL)-

Preferred Name

English

OXOTREMORINE M

Common Name

English

N,N,N-TRIMETHYL-4-(2-OXO-1-PYRROLIDINYL)-2-BUTYN-1-AMINIUM

Systematic Name

English

Code System Code Type Description

PUBCHEM

4629

Created by admin on Mon Mar 31 19:53:51 GMT 2025 , Edited by admin on Mon Mar 31 19:53:51 GMT 2025

PRIMARY

CAS

63939-65-1

Created by admin on Mon Mar 31 19:53:51 GMT 2025 , Edited by admin on Mon Mar 31 19:53:51 GMT 2025

PRIMARY

FDA UNII

VWS78J9ZUJ

Created by admin on Mon Mar 31 19:53:51 GMT 2025 , Edited by admin on Mon Mar 31 19:53:51 GMT 2025

PRIMARY

EPA CompTox

DTXSID30981277

Created by admin on Mon Mar 31 19:53:51 GMT 2025 , Edited by admin on Mon Mar 31 19:53:51 GMT 2025

PRIMARY

SUBSTANCE RECORD


					VWS78J9ZUJ